IES20180195A2 - Pharmaceutical hormone intermediates 11-ketone-16α, 17α-epoxy progesterone synthesis method - Google Patents

Pharmaceutical hormone intermediates 11-ketone-16α, 17α-epoxy progesterone synthesis method

Info

Publication number
IES20180195A2
IES20180195A2 IES20180195A IES20180195A2 IE S20180195 A2 IES20180195 A2 IE S20180195A2 IE S20180195 A IES20180195 A IE S20180195A IE S20180195 A2 IES20180195 A2 IE S20180195A2
Authority
IE
Ireland
Prior art keywords
solution
ketone
epoxy progesterone
washed
several times
Prior art date
Application number
Inventor
Guan Genan
Original Assignee
Chengdu Qianye Longhua Petroleum Engineering Tech Consulting Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chengdu Qianye Longhua Petroleum Engineering Tech Consulting Co Ltd filed Critical Chengdu Qianye Longhua Petroleum Engineering Tech Consulting Co Ltd
Publication of IES20180195A2 publication Critical patent/IES20180195A2/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005Oxygen-containing hetero ring
    • C07J71/001Oxiranes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention discloses pharmaceutical hormone intermediates11-ketone-16α,17α-epoxy progesterone synthesis method, comprises the following steps: 2-bromine-llα-hydroxy-14-amino-16α,17α-epoxy progesterone, sodium sulfate solution were added to the reaction vessel, controlled the stirring speed, controlled the temperature of the solution, reacted; added furan carboxylic acid ethyl ester solution and antimony trichloride powder, raised the temperature of the solution, reacted, added potassium chloride solution, lay up, got crystal, filter, washed with the sodium nitrate solution for several times, washed with the 2,6-dimethyl pyridine solution for several times, washed with the difluorodichloromethane solution for several times, re-crystallized in the diethylene glycol ether solution, dehydrated with dehydration, got the finished product 11-ketone-16α,17α-epoxy progesterone.
IES20180195 2017-07-01 2018-06-26 Pharmaceutical hormone intermediates 11-ketone-16α, 17α-epoxy progesterone synthesis method IES20180195A2 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201710527156.9A CN108239137A (en) 2017-07-01 2017-07-01 Medical -16 α of hormone intermediate 11- ketone, the synthetic method of 17 α-epoxy progesterone

Publications (1)

Publication Number Publication Date
IES20180195A2 true IES20180195A2 (en) 2019-11-13

Family

ID=59996619

Family Applications (1)

Application Number Title Priority Date Filing Date
IES20180195 IES20180195A2 (en) 2017-07-01 2018-06-26 Pharmaceutical hormone intermediates 11-ketone-16α, 17α-epoxy progesterone synthesis method

Country Status (4)

Country Link
CN (1) CN108239137A (en)
AU (1) AU2018100819A4 (en)
GB (1) GB201713391D0 (en)
IE (1) IES20180195A2 (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2019037743A1 (en) * 2017-08-22 2019-02-28 中国石油化工股份有限公司 Starch-containing microsphere and preparation method therefor and application thereof

Also Published As

Publication number Publication date
CN108239137A (en) 2018-07-03
GB201713391D0 (en) 2017-10-04
AU2018100819A4 (en) 2018-08-02

Similar Documents

Publication Publication Date Title
CN104327119A (en) Preparation method of tedizolid phosphate
MX377644B (en) Steroid 6.7.beta.-epoxides as chemical intermediates
IES20180195A2 (en) Pharmaceutical hormone intermediates 11-ketone-16α, 17α-epoxy progesterone synthesis method
IES20180196A2 (en) Hormone drug intermediates 9(11)-pregnene-16β-methyl-17α, 21-glycol-3, 20-diketone-21-acetate synthesis method
IE20180194U1 (en) Pharmaceutical intermediates androstane-2,3-break-17-ketone-2,3-dicarboxylic acid synthesis method
IE20180280U1 (en) Methylchloroperoxybenzoic acid drug intermediates synthesis method
IES20180251U1 (en) Nicotinamide-n-oxide drug intermediates synthesis method
IES20180291A2 (en) Acetone dicarboxylic acid drug intermediates synthesis method
IES20180088A2 (en) Drugs intermediates 2-ethylhexanoic acid synthesis method
MY177491A (en) Method for producing monoglyceride-containing composition
IE20180281U1 (en) Benzoyl peroxide organic intermediates synthesis method
IES20180113A2 (en) Drug intermediates p-benzoylbenzoic acid synthesis method
IES20180200A2 (en) Anti-clavicular spirochete drugs ethyl imidazole synthesis method
IE20180288U1 (en) P-methoxphenylacetic acid drug intermediates synthesis method
PH12019550260A1 (en) Process for preparing polyesters by using an additive
IES20180086A2 (en) Drug intermediates isovaleric acid synthesis method
AU2018100523A4 (en) Vitamin E acetate intermediates 2,3,5-trimethylbenzoquinone synthesis method
IES20180117A2 (en) Drug synthesis intermediates p-carboxybenzenesulfonic amide synthesis method
IES20180253U1 (en) Tert-butyl hydroperoxide drug intermediates synthesis method
CN108997340B (en) Synthetic method of 5-bromo-7-azaindole
IES20180267U1 (en) Aminoquinone drug intermediates tetrachlorobenzoquinone synthesis method
IE20180282U1 (en) Dodecanoyl peroxide organic intermediates synthesis method
IES20180250A2 (en) Butyraldehyde oxime drug itermediates synthesis method
IES20180187A2 (en) Drug intermediates 4-benzyloxy-3-methoxy-4'-methylbenzophenone synthesis method
IES20180272U1 (en) Post-efficiency promoter n-cyclohexyl-2-benzothiazole sulfenamide synthesis method

Legal Events

Date Code Title Description
FJ9A Application deemed to be withdrawn section 31(3)